Targeted rescue of cancer-associated IDH1 mutant activity using an engineered synthetic antibody
dc.contributor.author | Rizk, Shahir S. | |
dc.contributor.author | Mukherjee, Somnath | |
dc.contributor.author | Koide, Akiko | |
dc.contributor.author | Koide, Shohei | |
dc.contributor.author | Kossiakoff, Anthony A. | |
dc.contributor.department | Department of Biochemistry and Molecular Biology, School of Medicine | en_US |
dc.date.accessioned | 2017-08-24T17:55:08Z | |
dc.date.available | 2017-08-24T17:55:08Z | |
dc.date.issued | 2017-04-03 | |
dc.description.abstract | We have utilized a high-diversity phage display library to engineer antibody fragments (Fabs) that can modulate the activity of the enzyme isocitrate dehydrogenase 1 (IDH1). We show that a conformation-specific Fab can reactivate an IDH1 mutant associated with brain tumors. The results show that this strategy is a first step towards developing "activator drugs" for a large number of genetic disorders where mutations have disrupted protein function. | en_US |
dc.identifier.citation | Rizk, S. S., Mukherjee, S., Koide, A., Koide, S., & Kossiakoff, A. A. (2017). Targeted rescue of cancer-associated IDH1 mutant activity using an engineered synthetic antibody. Scientific Reports, 7, 556. http://doi.org/10.1038/s41598-017-00728-1 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/13909 | |
dc.language.iso | en_US | en_US |
dc.publisher | SpringerNature | en_US |
dc.relation.isversionof | 10.1038/s41598-017-00728-1 | en_US |
dc.relation.journal | Scientific Reports | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | |
dc.source | PMC | en_US |
dc.subject | Antibody fragments (Fabs) | en_US |
dc.subject | Enzyme isocitrate dehydrogenase 1 (IDH1) | en_US |
dc.subject | IDH1 mutant associated with brain tumors | en_US |
dc.subject | Protein function | en_US |
dc.subject | Mutations | en_US |
dc.title | Targeted rescue of cancer-associated IDH1 mutant activity using an engineered synthetic antibody | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 41598_2017_Article_728.pdf
- Size:
- 1.75 MB
- Format:
- Adobe Portable Document Format
- Description:
- Main Article
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.88 KB
- Format:
- Item-specific license agreed upon to submission
- Description: